As of 2025-04-22, the Intrinsic Value of 9 Meters Biopharma Inc (NMTR) is -9.35 USD. This NMTR valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.07 USD, the upside of 9 Meters Biopharma Inc is -13,054.50%.
Based on its market price of 0.07 USD and our intrinsic valuation, 9 Meters Biopharma Inc (NMTR) is overvalued by 13,054.50%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -9.35 - -9.35 | -9.35 | -13,054.50% |
| P/E | (30.83) - (37.08) | (33.11) | -45959.0% |
| DDM - Stable | (13.31) - (43.60) | (28.46) | -39514.0% |
| DDM - Multi | (11.12) - (29.81) | (16.38) | -22782.8% |
| Market Cap (mil) | 1.04 |
| Beta | 1.47 |
| Outstanding shares (mil) | 14.46 |
| Enterprise Value (mil) | -0.82 |
| Market risk premium | 5.00% |
| Cost of Equity | 10.85% |
| Cost of Debt | 5.00% |
| WACC | 5.44% |